Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial.
van den Berg SA, Uniken Venema SM, Reinink H, Hofmeijer J, Schonewille WJ, Miedema I, Fransen PSS, O Pruissen DM, Raaijmakers TWM, van Dijk GW, de Leeuw FE, van Vliet JA, Kwa VIH, Kerkhoff H, van 't Net A, Boomars R, Siegers A, Lok T, Caminada K, Esteve Cuevas LM, Visser MC, Zwetsloot CP, Boomsma JMF, Schipper MH, van Eijkelenburg RPJ, Berkhemer OA, Nieboer D, Lingsma HF, Emmer BJ, van Oostenbrugge RJ, van der Lugt A, Roos YBWEM, Majoie CBLM, Dippel DWJ, Nederkoorn PJ, van der Worp HB; MR ASAP Investigators. van den Berg SA, et al. Among authors: berkhemer oa. Lancet Neurol. 2022 Nov;21(11):971-981. doi: 10.1016/S1474-4422(22)00333-7. Epub 2022 Sep 1. Lancet Neurol. 2022. PMID: 36058230 Clinical Trial.
Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN).
Yoo AJ, Berkhemer OA, Fransen PSS, van den Berg LA, Beumer D, Lingsma HF, Schonewille WJ, Sprengers MES, van den Berg R, van Walderveen MAA, Beenen LFM, Wermer MJH, Nijeholt GJLÀ, Boiten J, Jenniskens SFM, Bot JCJ, Boers AMM, Marquering HA, Roos YBWEM, van Oostenbrugge RJ, Dippel DWJ, van der Lugt A, van Zwam WH, Majoie CBLM; MR CLEAN investigators. Yoo AJ, et al. Among authors: berkhemer oa. Lancet Neurol. 2016 Jun;15(7):685-694. doi: 10.1016/S1474-4422(16)00124-1. Epub 2016 May 9. Lancet Neurol. 2016. PMID: 27302238 Clinical Trial.
The effect of anesthetic management during intra-arterial therapy for acute stroke in MR CLEAN.
Berkhemer OA, van den Berg LA, Fransen PS, Beumer D, Yoo AJ, Lingsma HF, Schonewille WJ, van den Berg R, Wermer MJ, Boiten J, Lycklama À Nijeholt GJ, Nederkoorn PJ, Hollmann MW, van Zwam WH, van der Lugt A, van Oostenbrugge RJ, Majoie CB, Dippel DW, Roos YB; MR CLEAN investigators. Berkhemer OA, et al. Neurology. 2016 Aug 16;87(7):656-64. doi: 10.1212/WNL.0000000000002976. Epub 2016 Jul 15. Neurology. 2016. PMID: 27421546 Clinical Trial.
Intra-arterial therapy for acute ischaemic stroke.
Berkhemer OA, Dippel DW. Berkhemer OA, et al. Lancet Neurol. 2016 Oct;15(11):1105-7. doi: 10.1016/S1474-4422(16)30197-1. Epub 2016 Aug 23. Lancet Neurol. 2016. PMID: 27567240 No abstract available.
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial.
van der Steen W, van de Graaf RA, Chalos V, Lingsma HF, van Doormaal PJ, Coutinho JM, Emmer BJ, de Ridder I, van Zwam W, van der Worp HB, van der Schaaf I, Gons RAR, Yo LSF, Boiten J, van den Wijngaard I, Hofmeijer J, Martens J, Schonewille W, Vos JA, Tuladhar AM, de Laat KF, van Hasselt B, Remmers M, Vos D, Rozeman A, Elgersma O, Uyttenboogaart M, Bokkers RPH, van Tuijl J, Boukrab I, van den Berg R, Beenen LFM, Roosendaal SD, Postma AA, Krietemeijer M, Lycklama G, Meijer FJA, Hammer S, van der Hoorn A, Yoo AJ, Gerrits D, Truijman MTB, Zinkstok S, Koudstaal PJ, Manschot S, Kerkhoff H, Nieboer D, Berkhemer O, Wolff L, van der Sluijs PM, van Voorst H, Tolhuisen M, Roos YBWEM, Majoie CBLM, Staals J, van Oostenbrugge RJ, Jenniskens SFM, van Dijk LC, den Hertog HM, van Es ACGM, van der Lugt A, Dippel DWJ, Roozenbeek B; MR CLEAN-MED investigators. van der Steen W, et al. Lancet. 2022 Mar 12;399(10329):1059-1069. doi: 10.1016/S0140-6736(22)00014-9. Epub 2022 Feb 28. Lancet. 2022. PMID: 35240044 Clinical Trial.
Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical Trial.
Fransen PS, Berkhemer OA, Lingsma HF, Beumer D, van den Berg LA, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Lycklama À Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog HM, Gerrits DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van Oostenbrugge RJ, Majoie CB, van der Lugt A, Dippel DW; Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands Investigators. Fransen PS, et al. Among authors: berkhemer oa. JAMA Neurol. 2016 Feb;73(2):190-6. doi: 10.1001/jamaneurol.2015.3886. JAMA Neurol. 2016. PMID: 26716735 Clinical Trial.
Early effect of intra-arterial treatment in ischemic stroke on aphasia recovery in MR CLEAN.
Crijnen YS, Nouwens F, de Lau LM, Visch-Brink EG, van de Sandt-Koenderman MW, Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Roos YB, van der Lugt A, van Oostenbrugge RJ, van Zwam WH, Majoie CB, Dippel DW; MR CLEAN investigators. Crijnen YS, et al. Among authors: berkhemer oa. Neurology. 2016 May 31;86(22):2049-55. doi: 10.1212/WNL.0000000000002724. Epub 2016 May 11. Neurology. 2016. PMID: 27170565 Clinical Trial.
Influence of Device Choice on the Effect of Intra-Arterial Treatment for Acute Ischemic Stroke in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands).
Dippel DW, Majoie CB, Roos YB, van der Lugt A, van Oostenbrugge RJ, van Zwam WH, Lingsma HF, Koudstaal PJ, Treurniet KM, van den Berg LA, Beumer D, Fransen PS, Berkhemer OA; MR CLEAN Investigators. Dippel DW, et al. Among authors: berkhemer oa. Stroke. 2016 Oct;47(10):2574-81. doi: 10.1161/STROKEAHA.116.013929. Epub 2016 Sep 6. Stroke. 2016. PMID: 27601379 Clinical Trial.
Is Intra-Arterial Treatment for Acute Ischemic Stroke Less Effective in Women than in Men?
de Ridder IR, Fransen PS, Beumer D, Berkhemer OA, van den Berg LA, Wermer MJ, Lingsma H, van Zwam WH, Roos YB, van Oostenbrugge RJ, Majoie CB, van der Lugt A, Dippel DW. de Ridder IR, et al. Among authors: berkhemer oa. Interv Neurol. 2016 Sep;5(3-4):174-178. doi: 10.1159/000447331. Epub 2016 Jul 1. Interv Neurol. 2016. PMID: 27781046 Free PMC article.
Does prior antiplatelet treatment improve functional outcome after intra-arterial treatment for acute ischemic stroke?
Mulder MJ, Berkhemer OA, Fransen PS, van den Berg LA, Lingsma HF, den Hertog HM, Staals J, Jenniskens SF, van Oostenbrugge RJ, van Zwam WH, Majoie CB, van der Lugt A, Dippel DW; MR CLEAN investigators. Mulder MJ, et al. Among authors: berkhemer oa. Int J Stroke. 2017 Jun;12(4):368-376. doi: 10.1177/1747493016677842. Epub 2016 Jan 1. Int J Stroke. 2017. PMID: 27807281
152 results